Cargando…

The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study

BACKGROUND: Positive inotropic and renal protective actions of glucocorticoids have been observed clinically. Therefore, glucocorticoids may be used in patients with heart failure and low blood pressure (HF-LBP). METHODS: The medical records of 144 consecutive patients with HF-LBP who received gluco...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuyu, Zhao, Qingzhen, Zhen, Yuzhi, Li, Lizhuo, Mi, Yiqing, Li, Tongxin, Liu, Kunshen, Liu, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520478/
https://www.ncbi.nlm.nih.gov/pubmed/34675630
http://dx.doi.org/10.2147/IJGM.S334132
_version_ 1784584681409216512
author Li, Shuyu
Zhao, Qingzhen
Zhen, Yuzhi
Li, Lizhuo
Mi, Yiqing
Li, Tongxin
Liu, Kunshen
Liu, Chao
author_facet Li, Shuyu
Zhao, Qingzhen
Zhen, Yuzhi
Li, Lizhuo
Mi, Yiqing
Li, Tongxin
Liu, Kunshen
Liu, Chao
author_sort Li, Shuyu
collection PubMed
description BACKGROUND: Positive inotropic and renal protective actions of glucocorticoids have been observed clinically. Therefore, glucocorticoids may be used in patients with heart failure and low blood pressure (HF-LBP). METHODS: The medical records of 144 consecutive patients with HF-LBP who received glucocorticoids as an adjunctive treatment to facilitate the up-titration of β-blocker and angiotensin-converting enzyme inhibitor were reviewed. RESULTS: After four weeks of treatment, the metoprolol and captopril (or equivalent) dosages were progressively and consistently increased from 25 (interquartile range [IQR] = 12.5–75 mg/day) to 100 mg/day (IQR = 50–178.8 mg/day) and from 0 (IQR = 0–25 mg/day) to 12.5 mg/day (IQR = 0–50 mg/day), respectively. There was a remarkable beneficial hemodynamic response to the glucocorticoid treatment signified by an increase in blood pressure and decrease in heart rate. The average heart rate decreased by 6 beat per minute (bpm) (0.5–16 bpm), and the mean arterial blood pressure increased from 74.06 ± 7.81 to 78.85 ± 7.91 mmHg. We also observed an improvement in renal function and an increased diuretic response following glucocorticoid treatment. As a result, the left ventricular ejection fraction increased from 28.92 ± 8.06% to 33.86 ± 8.76%, and the diuretic response increased from 776.7 mL/40 mg furosemide (IQR = 133.8–2000 mL) to 4000 mL/40 mg furosemide on day 28 (IQR = 2200–5925 mL). CONCLUSION: The use of glucocorticoid treatment to maintain hemodynamic and renal functional targets when titrating guideline-directed medical treatment in patients with HF-LBP may be safe, effective, and feasible.
format Online
Article
Text
id pubmed-8520478
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85204782021-10-20 The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study Li, Shuyu Zhao, Qingzhen Zhen, Yuzhi Li, Lizhuo Mi, Yiqing Li, Tongxin Liu, Kunshen Liu, Chao Int J Gen Med Original Research BACKGROUND: Positive inotropic and renal protective actions of glucocorticoids have been observed clinically. Therefore, glucocorticoids may be used in patients with heart failure and low blood pressure (HF-LBP). METHODS: The medical records of 144 consecutive patients with HF-LBP who received glucocorticoids as an adjunctive treatment to facilitate the up-titration of β-blocker and angiotensin-converting enzyme inhibitor were reviewed. RESULTS: After four weeks of treatment, the metoprolol and captopril (or equivalent) dosages were progressively and consistently increased from 25 (interquartile range [IQR] = 12.5–75 mg/day) to 100 mg/day (IQR = 50–178.8 mg/day) and from 0 (IQR = 0–25 mg/day) to 12.5 mg/day (IQR = 0–50 mg/day), respectively. There was a remarkable beneficial hemodynamic response to the glucocorticoid treatment signified by an increase in blood pressure and decrease in heart rate. The average heart rate decreased by 6 beat per minute (bpm) (0.5–16 bpm), and the mean arterial blood pressure increased from 74.06 ± 7.81 to 78.85 ± 7.91 mmHg. We also observed an improvement in renal function and an increased diuretic response following glucocorticoid treatment. As a result, the left ventricular ejection fraction increased from 28.92 ± 8.06% to 33.86 ± 8.76%, and the diuretic response increased from 776.7 mL/40 mg furosemide (IQR = 133.8–2000 mL) to 4000 mL/40 mg furosemide on day 28 (IQR = 2200–5925 mL). CONCLUSION: The use of glucocorticoid treatment to maintain hemodynamic and renal functional targets when titrating guideline-directed medical treatment in patients with HF-LBP may be safe, effective, and feasible. Dove 2021-10-12 /pmc/articles/PMC8520478/ /pubmed/34675630 http://dx.doi.org/10.2147/IJGM.S334132 Text en © 2021 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Shuyu
Zhao, Qingzhen
Zhen, Yuzhi
Li, Lizhuo
Mi, Yiqing
Li, Tongxin
Liu, Kunshen
Liu, Chao
The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study
title The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study
title_full The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study
title_fullStr The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study
title_full_unstemmed The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study
title_short The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study
title_sort impact of glucocorticoid therapy on guideline-directed medical treatment titration in patients hospitalized for heart failure with low blood pressure: a retrospective study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520478/
https://www.ncbi.nlm.nih.gov/pubmed/34675630
http://dx.doi.org/10.2147/IJGM.S334132
work_keys_str_mv AT lishuyu theimpactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT zhaoqingzhen theimpactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT zhenyuzhi theimpactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT lilizhuo theimpactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT miyiqing theimpactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT litongxin theimpactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT liukunshen theimpactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT liuchao theimpactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT lishuyu impactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT zhaoqingzhen impactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT zhenyuzhi impactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT lilizhuo impactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT miyiqing impactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT litongxin impactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT liukunshen impactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy
AT liuchao impactofglucocorticoidtherapyonguidelinedirectedmedicaltreatmenttitrationinpatientshospitalizedforheartfailurewithlowbloodpressurearetrospectivestudy